Long-term follow-up of patients with hypoparathyroidism - Test2 - elhamkhani - TriplyDB

Long-term follow-up of patients with hypoparathyroidism

Long-term follow-up of patients with hypoparathyroidism

http://www.wikidata.org/entity/Q28276548

about

Hypoparathyroidism: Replacement Therapy with Parathyroid Hormone Therapy of hypoparathyroidism by replacement with parathyroid hormone Defining the syndromes of parathyroid failure after total thyroidectomy Epidemiology and Diagnosis of Hypoparathyroidism.Management of Hypoparathyroidism: Present and Future.The pros and cons of prophylactic central neck dissection in papillary thyroid carcinoma.Effects of pump versus twice-daily injection delivery of synthetic parathyroid hormone 1-34 in children with severe congenital hypoparathyroidism.PTH(1-84) is associated with improved quality of life in hypoparathyroidism through 5 years of therapy Parathyroid hormone therapy for hypoparathyroidism Use of parathyroid hormone in hypoparathyroidism.PTH(1-84) replacement therapy for the treatment of hypoparathyroidism.A Homozygous [Cys25]PTH(1-84) Mutation That Impairs PTH/PTHrP Receptor Activation Defines a Novel Form of Hypoparathyroidism.Noninvasive Assessment of Skeletal Microstructure and Estimated Bone Strength in Hypoparathyroidism.The effect of PTH(1-84) on quality of life in hypoparathyroidism.Diphtheria Toxin- and GFP-Based Mouse Models of Acquired Hypoparathyroidism and Treatment With a Long-Acting Parathyroid Hormone Analog.Effects of Parathyroid Hormone Administration on Bone Strength in Hypoparathyroidism Therapy of Hypoparathyroidism With PTH(1-84): A Prospective Six Year Investigation of Efficacy and Safety.Epidemiology and Health-Related Quality of Life in Hypoparathyroidism in Norway Genetic and clinical characteristics of korean patients with isolated hypoparathyroidism: from the Korean hypopara registry study.Pseudohypoparathyroidism type I-b with neurological involvement is associated with a homozygous PTH1R mutation.Potential role of carbon nanoparticles in protection of parathyroid glands in patients with papillary thyroid cancer.Identification of an orally active small-molecule PTHR1 agonist for the treatment of hypoparathyroidism.Prolonged Pharmacokinetic and Pharmacodynamic Actions of a Pegylated Parathyroid Hormone (1-34) Peptide Fragment.Effects of parathyroid hormone rhPTH(1-84) on phosphate homeostasis and vitamin D metabolism in hypoparathyroidism: REPLACE phase 3 study.Review of Hypoparathyroidism.Treatment related morbidity in differentiated thyroid cancer-a survey of clinicians Cardiovascular and renal complications to postsurgical hypoparathyroidism: a Danish nationwide controlled historic follow-up study.Natpara for the treatment of hypoparathyroidism.1,25-Dihydroxyvitamin D as Monotherapy for XLH: Back to the Future?Bone imaging in hypoparathyroidism.The Epidemiology of Hypoparathyroidism in Italy: An 8-Year Register-Based Study.Hypoparathyroidism and pseudohypoparathyroidism: etiology, laboratory features and complications.The true cost of thyroid surgery determined by a micro-costing approach.A case of psychosis due to Fahr's syndrome and response to behavioral disturbances with risperidone and oxcarbazepine.Pseudohypoparathyroidism - epidemiology, mortality and risk of complications.Visualizing fewer parathyroid glands may be associated with lower hypoparathyroidism following total thyroidectomy.Pharmacodynamic Actions of a Long-Acting PTH Analog (LA-PTH) in Thyroparathyroidectomized (TPTX) Rats and Normal Monkeys.The use of ICG enhanced fluorescence for the evaluation of parathyroid gland preservation.Recombinant Parathyroid Hormone Versus Usual Care: Do the Outcomes Justify the Cost?Clinical profile and long-term follow-up of 32 patients with postoperative permanent hypoparathyroidism.

P2860

Q26782156-03A64F69-E71F-4EA9-94F2-63E95ABD6A84 Q26828582-1B23EA65-4332-4897-AA7D-FF0C04297484 Q28081425-942AF63F-041A-4BA9-9261-B306C42B1FCD Q33570602-7AFF8D23-657B-4F84-B23D-C344F5D2A3DF Q33570607-738FD3F8-6536-4A6F-B806-CCCE7731A544 Q33973108-791AC2BA-DDC6-4F38-B846-A05556CA555C Q34240782-CCE7D41E-4EB5-4EA8-A551-69D877DB853E Q34284783-1A2B08DB-06D2-420F-A492-C3F87F053B28 Q35014795-5130D66D-B699-44E4-A3D6-CF52A01BB333 Q35043115-89F974F1-5246-4CB5-80A6-DEFFBF9F8706 Q35100381-04E0887E-C6F7-4C5A-B997-72613F71C0A8 Q36087092-31AC6F63-52F4-41A2-9497-E541368A3591 Q36800736-09C800AC-F754-4024-A2DD-21CB1D9D69F0 Q36885818-0ABDAD20-3BD4-4528-9DB5-894940C39863 Q36889072-E54E4A4D-EF50-4ED5-A65B-9E5072BEBB59 Q36889099-0997FB42-A5BA-4904-A5A5-EA5DC0005978 Q37057936-237D8AAA-2FC9-4BF8-81E0-8BD48B7EA5D9 Q37147509-C0D4A1DA-B861-443B-AD85-AD23A2C48B5A Q37220483-59FE0F5C-E133-4B9E-92C8-06A21392221E Q37261600-16505DC1-E112-4FC1-84D4-FB228CF8A9B9 Q37364924-5682219D-5981-4749-939C-BEE1DF4D70C4 Q37430684-37637B9E-278F-47D6-826C-4739027CC2DC Q37544925-1AB88079-6788-4EF9-A353-5E1DD2072ED1 Q37578427-7005A411-11FF-483D-98FB-C0B0BE707328 Q37587224-ACE6E29D-4A2C-40CE-8CAA-09E9312084BB Q37683923-8160DB0B-5DBB-4ABD-B364-DF8730F5D291 Q38105497-845E0C25-3F47-44AC-BC3D-6FA6133D2F07 Q38816021-E1D08894-4C7E-4D8D-B4CF-3B089E439958 Q38879138-0AF9FFA9-565A-4BE4-844F-9469B3800900 Q38941679-B1A0E20C-93D4-41C0-9A82-11407DC06036 Q39067240-F885530A-8E8C-4BB4-A679-AD5F6B7F485A Q39143531-2FFD1FFF-7000-488B-967B-CBC1AC4FA75A Q39771398-AEDA718B-1C9B-4D00-9003-ED8D8144C244 Q40117691-FFB80389-C11F-4FEA-8D3A-B4071A608FD7 Q40521417-1968F75A-80E8-4D42-8A25-10DF71555A8D Q40900761-DBAF304B-222F-430D-AFB8-A8DC322215FC Q42014841-03D523F3-73D5-41D1-A0B2-BE11FB298340 Q45340009-F12F5038-8D1F-43EB-B6DE-F9B2B0ADDFD9 Q46438384-0390FD8E-C3E6-4503-A994-2E54A2F025FD Q47555326-6B8438A7-D3CF-4DE8-8357-7EC2C86D8CFF

P2860

Long-term follow-up of patients with hypoparathyroidism

http://www.wikidata.org/entity/Q28276548

description

2012 nî lūn-bûn

@nan

2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Long-term follow-up of patients with hypoparathyroidism

@ast

Long-term follow-up of patients with hypoparathyroidism

@en

Long-term follow-up of patients with hypoparathyroidism

@nl

type

label

Long-term follow-up of patients with hypoparathyroidism

@ast

Long-term follow-up of patients with hypoparathyroidism

@en

Long-term follow-up of patients with hypoparathyroidism

@nl

prefLabel

Long-term follow-up of patients with hypoparathyroidism

@ast

Long-term follow-up of patients with hypoparathyroidism

@en

Long-term follow-up of patients with hypoparathyroidism

@nl

P1433

Q28276548-71FBAF49-8A05-4459-AF7A-F8FC71E44D39

P1476

Q28276548-CD0C8616-C979-46A4-90A5-CF12A8FBD2D9

P2093

Q28276548-0A663583-837E-47CF-88BB-20A944FF517F

Q28276548-6B9A4EEB-0AF8-48BF-B556-13E1ECDA1142

Q28276548-92C9054B-178A-4C91-AE9D-29994199570B

Q28276548-AA3CF613-929D-41F0-91CD-A9272F08FC70

Q28276548-D2BB0657-6A8F-434A-AB42-F1A08BC17C91

Q28276548-E6544C52-BC92-46F8-9788-09F538CC7E9D

P2860

Q28276548-059C44C2-6968-4B86-8772-1462EE938D6A

Q28276548-0981CCDA-955B-43EE-982E-FD8DB181322C

Q28276548-0A32DEFD-E435-4CB3-80FB-8EE20A872456

Q28276548-0B30892E-7D42-409F-8662-ABF344D59128

Q28276548-122EA634-2816-4C16-BFEB-D713E6ED8DC2

Q28276548-150DD390-1FA2-4007-8D59-61B852BFE358

Q28276548-1630B589-9C12-4305-9EE4-04D4411EAE69

Q28276548-261F4B8A-E305-40D9-A3E7-D6822B97CF7C

Q28276548-4A897808-C188-4E91-9E2C-00B3119C87E3

Q28276548-563C9CCF-EE86-4A87-BB1B-505F840313CF

P304

Q28276548-940C1C95-9C1C-4616-A080-DF4921DB994D

P31

Q28276548-64A42B40-8063-4081-8561-E06EB6F94E1C

P3181

Q28276548-3CF4B8DD-C526-49E9-BCC0-10DD29B72ECF

P356

Q28276548-43865A17-3EC7-4045-A1A0-B9B82C28DCE2

P407

Q28276548-F374BA02-CACF-48BF-885E-0174BBB750B2

P433

Q28276548-98BF8F51-DC4F-402B-B2BF-4B099424B6CC

P478

Q28276548-3F0D09D7-3AAD-4178-A7DC-08F6188811AA

P50

Q28276548-15D997F3-37BE-492C-B90B-EAA8FCE12CDD

Q28276548-95AA2EEB-DE54-4042-8A79-340076C52299

P577

Q28276548-8BB7D989-3923-4D38-A29F-D3C6544B305F

P698

Q28276548-B7DDB6C4-F158-4FD9-87B8-A84618FE59F4

P921

Q28276548-0A51D53A-EF3E-474F-AC89-4B84CC46657D

P932

Q28276548-A7EAB19D-B444-4B3B-B6B4-2C7407B18011

P3181

P356

P1433

The Journal of Clinical Endocrinology and Metabolism

P1476

Long-term follow-up of patients with hypoparathyroidism

@en

P2093

Carolyn B Becker

http://www.w3.org/2001/XMLSchema#string

Kelly B Lauter

http://www.w3.org/2001/XMLSchema#string

Michael C Vrla

http://www.w3.org/2001/XMLSchema#string

Michael Mannstadt

http://www.w3.org/2001/XMLSchema#string

Michael R Cooley

http://www.w3.org/2001/XMLSchema#string

Susan Regan

http://www.w3.org/2001/XMLSchema#string

P2860

Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research

A new equation to estimate glomerular filtration rate

A donor splice site mutation in the parathyroid hormone gene is associated with autosomal recessive hypoparathyroidism

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

Calculating the benefits of a Research Patient Data Repository.

Long-term treatment of 12 children with chronic hypoparathyroidism: a randomized trial comparing synthetic human parathyroid hormone 1-34 versus calcitriol and calcium.

Hyperparathyroid and hypoparathyroid disorders.

Therapy of hypoparathyroidism with intact parathyroid hormone.

Mutations in SLC20A2 link familial idiopathic basal ganglia calcification with phosphate homeostasis.

A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor.

P304

4507-4514

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1598025

http://www.w3.org/2001/XMLSchema#string

P356

10.1210/JC.2012-1808

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

97

http://www.w3.org/2001/XMLSchema#string

P50

Sherri-Ann M Burnett-Bowie

Deborah M Mitchell

P577

2012-10-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23043192

http://www.w3.org/2001/XMLSchema#string

P921

clinical chemistry

P932

3513540

http://www.w3.org/2001/XMLSchema#string